{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T06:11:22Z","timestamp":1780380682846,"version":"3.54.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Center for Experimental Immuno-Oncology Fellowship Award","award":["AWD00000754"],"award-info":[{"award-number":["AWD00000754"]}]},{"name":"The Tow Foundation and Center for Molecular Imaging and Nanotechnology (CMINT) Fellowship Award","award":["AWD00002040"],"award-info":[{"award-number":["AWD00002040"]}]},{"name":"The Fiona and Stanley Druckenmiller Center for Lung Cancer Research Fellowship Award","award":["AWD00002441"],"award-info":[{"award-number":["AWD00002441"]}]},{"name":"NIH\/NCI Cancer Center Support Grant","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]},{"name":"NIH\/NCI Cancer Center Support Grant","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]},{"DOI":"10.13039\/100000057","name":"NIGMS","doi-asserted-by":"crossref","award":["R01GM150804"],"award-info":[{"award-number":["R01GM150804"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CRI Lloyd J. Old STAR","award":["CRI5589"],"award-info":[{"award-number":["CRI5589"]}]},{"name":"NIH","award":["R01 CA220524-01A1"],"award-info":[{"award-number":["R01 CA220524-01A1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Imaging"],"DOI":"10.1038\/s44303-025-00127-6","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T07:20:41Z","timestamp":1763968841000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Practical considerations for clinical translation of PET imaging of adoptive cell therapies"],"prefix":"10.1038","volume":"3","author":[{"given":"Alessia","family":"Volpe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Sellmyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Ponomarev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"127_CR1","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1056\/NEJMoa2408771","volume":"392","author":"J Svoboda","year":"2025","unstructured":"Svoboda, J. et al. Enhanced CAR T-cell therapy for lymphoma after previous failure. N. Engl. J. Med. 392, 1824\u20131835 (2025).","journal-title":"N. Engl. J. Med."},{"key":"127_CR2","doi-asserted-by":"crossref","unstructured":"Majzner, R. G. et al. GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas. Nature 603, 934\u2013941 (2022).","DOI":"10.1038\/s41586-022-04489-4"},{"key":"127_CR3","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3389\/fimmu.2019.00128","volume":"10","author":"M Martinez","year":"2019","unstructured":"Martinez, M. & Moon, E. K. CAR T cells for solid tumors: new strategies for finding, infiltrating, and surviving in the tumor microenvironment. Front Immunol. 10, 128 (2019).","journal-title":"Front Immunol."},{"key":"127_CR4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.trecan.2018.03.009","volume":"4","author":"W Wei","year":"2018","unstructured":"Wei, W., Jiang, D., Ehlerding, E. B., Luo, Q. & Cai, W. Noninvasive PET imaging of T cells. Trends Cancer 4, 359\u2013373 (2018).","journal-title":"Trends Cancer"},{"key":"127_CR5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2967\/jnumed.121.261976","volume":"63","author":"C Li","year":"2022","unstructured":"Li, C. et al. Visualizing T-cell responses: the T-cell PET imaging toolbox. J. Nucl. Med. 63, 183\u2013188 (2022).","journal-title":"J. Nucl. Med."},{"key":"127_CR6","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.omto.2021.03.003","volume":"20","author":"R Sakemura","year":"2021","unstructured":"Sakemura, R., Can, I., Siegler, E. L. & Kenderian, S. S. In vivo CART cell imaging: paving the way for success in CART cell therapy. Mol. Ther. Oncolytics 20, 625\u2013633 (2021).","journal-title":"Mol. Ther. Oncolytics"},{"key":"127_CR7","doi-asserted-by":"crossref","unstructured":"Volpe, A., Adusumilli, P. S., Sch\u00f6der, H., Ponomarev, V. Imaging cellular immunotherapies and immune cell biomarkers: from preclinical studies to patients. J Immunother Cancer 10, e004902 (2022).","DOI":"10.1136\/jitc-2022-004902"},{"key":"127_CR8","doi-asserted-by":"crossref","unstructured":"Jacob, J. et al. Radiolabelling of polyclonally expanded human regulatory T cells (Treg) with (89)Zr-oxine for medium-term in vivo cell tracking. Molecules 28, 1482 (2023).","DOI":"10.3390\/molecules28031482"},{"key":"127_CR9","doi-asserted-by":"publisher","first-page":"e236","DOI":"10.1016\/S1470-2045(24)00030-5","volume":"25","author":"SE Lapi","year":"2024","unstructured":"Lapi, S. E. et al. Recent advances and impending challenges for the radiopharmaceutical sciences in oncology. Lancet Oncol. 25, e236\u2013e249 (2024).","journal-title":"Lancet Oncol."},{"key":"127_CR10","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1053\/j.semnuclmed.2011.02.003","volume":"41","author":"S Vallabhajosula","year":"2011","unstructured":"Vallabhajosula, S., Solnes, L. & Vallabhajosula, B. A broad overview of positron emission tomography radiopharmaceuticals and clinical applications: What is new?. Semin Nucl. Med. 41, 246\u2013264 (2011).","journal-title":"Semin Nucl. Med."},{"key":"127_CR11","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.omto.2021.01.017","volume":"20","author":"A Volpe","year":"2021","unstructured":"Volpe, A., Pillarsetty, N. V. K., Lewis, J. S. & Ponomarev, V. Applications of nuclear-based imaging in gene and cell therapy: probe considerations. Mol. Ther. Oncolytics 20, 447\u2013458 (2021).","journal-title":"Mol. Ther. Oncolytics"},{"key":"127_CR12","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1016\/j.ymthe.2020.06.028","volume":"28","author":"A Volpe","year":"2020","unstructured":"Volpe, A. et al. Spatiotemporal PET imaging reveals differences in CAR-T tumor retention in triple-negative breast cancer models. Mol. Ther. 28, 2271\u20132285 (2020).","journal-title":"Mol. Ther."},{"key":"127_CR13","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ymthe.2018.10.006","volume":"27","author":"F Man","year":"2019","unstructured":"Man, F. et al. In vivo PET tracking of (89)Zr-labeled V\u03b39V\u03b42 T cells to mouse xenograft breast tumors activated with liposomal alendronate. Mol. Ther. 27, 219\u2013229 (2019).","journal-title":"Mol. Ther."},{"key":"127_CR14","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s11307-024-01923-z","volume":"26","author":"A Volpe","year":"2024","unstructured":"Volpe, A., Lyashchenko, S. K. & Ponomarev, V. Nuclear-based labeling of cellular immunotherapies: a simple protocol for preclinical Use. Mol. Imaging Biol. 26, 555\u2013568 (2024).","journal-title":"Mol. Imaging Biol."},{"key":"127_CR15","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/j.cell.2022.03.041","volume":"185","author":"L Labanieh","year":"2022","unstructured":"Labanieh, L. et al. Enhanced safety and efficacy of protease-regulated CAR-T cell receptors. Cell 185, 1745\u20131763.e1722 (2022).","journal-title":"Cell"},{"key":"127_CR16","doi-asserted-by":"publisher","first-page":"3564","DOI":"10.1016\/j.ymthe.2023.10.020","volume":"31","author":"IK Lee","year":"2023","unstructured":"Lee, I. K. et al. A genetically encoded protein tag for control and quantitative imaging of CAR T cell therapy. Mol. Ther. 31, 3564\u20133578 (2023).","journal-title":"Mol. Ther."},{"key":"127_CR17","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2967\/jnumed.119.226498","volume":"60","author":"RD Badawi","year":"2019","unstructured":"Badawi, R. D. et al. First human imaging studies with the EXPLORER total-body PET scanner. J. Nucl. Med. 60, 299\u2013303 (2019).","journal-title":"J. Nucl. Med."},{"key":"127_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2967\/jnumed.116.184028","volume":"59","author":"SR Cherry","year":"2018","unstructured":"Cherry, S. R. et al. Total-body PET: maximizing sensitivity to create new opportunities for clinical research and patient care. J. Nucl. Med. 59, 3\u201312 (2018).","journal-title":"J. Nucl. Med."},{"key":"127_CR19","doi-asserted-by":"publisher","first-page":"886546","DOI":"10.3389\/fimmu.2022.886546","volume":"13","author":"AN Khan","year":"2022","unstructured":"Khan, A. N. et al. Immunogenicity of CAR-T cell therapeutics: evidence, mechanism and mitigation. Front. Immunol. 13, 886546 (2022).","journal-title":"Front. Immunol."},{"key":"127_CR20","doi-asserted-by":"crossref","unstructured":"Keu, K. V. et al. Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma. Sci. Transl. Med. 9, eaag2196 (2017).","DOI":"10.1126\/scitranslmed.aag2196"},{"key":"127_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-025-60816-z","volume":"16","author":"TS Nowicki","year":"2025","unstructured":"Nowicki, T. S. et al. Human cancer-targeted immunity via transgenic hematopoietic stem cell progeny. Nat. Commun. 16, 1\u201314 (2025).","journal-title":"Nat. Commun."},{"key":"127_CR22","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.2967\/jnumed.115.159855","volume":"56","author":"MA Moroz","year":"2015","unstructured":"Moroz, M.A. et al. Comparative Analysis of T Cell Imaging with Human Nuclear Reporter Genes. J. Nucl. Med. 56, 1055\u20131060 (2015).","journal-title":"J. Nucl. Med."},{"key":"127_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57446-w","volume":"16","author":"GS Blizard","year":"2025","unstructured":"Blizard, G. S. et al. Monitoring mRNA vaccine antigen expression in vivo using PET\/CT. Nat. Commun. 16, 2234 (2025).","journal-title":"Nat. Commun."},{"key":"127_CR24","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1053\/j.semnuclmed.2010.05.002","volume":"40","author":"RS Harapanhalli","year":"2010","unstructured":"Harapanhalli, R. S. Food and Drug Administration requirements for testing and approval of new radiopharmaceuticals. Semin Nucl. Med. 40, 364\u2013384 (2010).","journal-title":"Semin Nucl. Med."},{"key":"127_CR25","unstructured":"Food and Drug Administration, HHS. Current good manufacturing practice for positron emission tomography drugs. Fed Regist 74, 65409\u201365436 (2009)."},{"key":"127_CR26","unstructured":"Final rule (21 CFR 361.1): radioactive drugs for certain research uses. Fed. Regist. 40, 31298\u201331311 https:\/\/www.ecfr.gov\/current\/title-21\/chapter-I\/subchapter-D\/part-361\/section-361.1 (1975)."},{"key":"127_CR27","unstructured":"FDA. Radioactive Drug Research Committee: Human Research Without An Investigational New Drug Application (U.S. Food & Drug Administration)."},{"key":"127_CR28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s41181-020-00110-z","volume":"5","author":"IM Jackson","year":"2020","unstructured":"Jackson, I. M. et al. Use of 55 PET radiotracers under approval of a Radioactive Drug Research Committee (RDRC). EJNMMI Radiopharm. Chem. 5, 24 (2020).","journal-title":"EJNMMI Radiopharm. Chem."},{"key":"127_CR29","unstructured":"Guidance for industry on exploratory investigational new drug studies; availability. Fed. Regist. 71 (10), 2551\u20132552 (2006)."},{"key":"127_CR30","unstructured":"Final rule (21 CFR 312): investigational new drug application Fed. Regist. 52, 8831\u20138847 https:\/\/www.ecfr.gov\/current\/title-21\/chapter-I\/subchapter-D\/part-312 (1987)."},{"key":"127_CR31","unstructured":"CDER. Guidance on Investigational New Drug Applications for Positron Emission Tomography Drugs 71802\u201371803 (Food and Drug Administration, 2012)."},{"key":"127_CR32","unstructured":"FDA. Nonclinical Laboratory Studies: Good Laboratory Practice Regulations 59985\u201360025 (Food and Drug Administration, 1978)."},{"key":"127_CR33","unstructured":"FDA. Considerations for the Development of Chimeric Antigen Receptor (CAR) T Cell Products (U.S. Food & Drug Administration, 2024)."},{"key":"127_CR34","unstructured":"FDA. Studying Multiple Versions of a Cellular or Gene Therapy Product in an Early-phase Clinical Trial (U.S. Food & Drug Administration, 2022)."},{"key":"127_CR35","doi-asserted-by":"crossref","unstructured":"Ewing, B. Small business innovation research\/small business technology transfer (SBIR\/STTR). In: Translational Interventional Radiology (eds Eltorai, A.E.M., Liu, T., Chand, R., Kalva, S.P.) Ch. 106 (Academic Press, 2023).","DOI":"10.1016\/B978-0-12-823026-8.00079-1"},{"key":"127_CR36","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1053\/j.semnuclmed.2010.03.006","volume":"40","author":"MM Graham","year":"2010","unstructured":"Graham, M. M. The clinical trials network of the society of nuclear medicine. Semin Nucl. Med 40, 327\u2013331 (2010).","journal-title":"Semin Nucl. Med"},{"key":"127_CR37","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.jcyt.2021.02.005","volume":"23","author":"BM Helfer","year":"2021","unstructured":"Helfer, B. M. et al. Options for imaging cellular therapeutics in vivo: a multi-stakeholder perspective. Cytotherapy 23, 757\u2013773 (2021).","journal-title":"Cytotherapy"},{"key":"127_CR38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ymthe.2019.10.007","volume":"28","author":"MA Sellmyer","year":"2020","unstructured":"Sellmyer, M. A. et al. Imaging CAR T cell trafficking with eDHFR as a PET reporter gene. Mol. Ther. 28, 42\u201351 (2020).","journal-title":"Mol. Ther."},{"key":"127_CR39","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/s41551-023-01060-y","volume":"7","author":"EC Pratt","year":"2023","unstructured":"Pratt, E. C. et al. Simultaneous quantitative imaging of two PET radiotracers via the detection of positron-electron annihilation and prompt gamma emissions. Nat. Biomed. Eng. 7, 1028\u20131039 (2023).","journal-title":"Nat. Biomed. Eng."}],"container-title":["npj Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44303-025-00127-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44303-025-00127-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44303-025-00127-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T18:18:58Z","timestamp":1764181138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44303-025-00127-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["127"],"URL":"https:\/\/doi.org\/10.1038\/s44303-025-00127-6","relation":{},"ISSN":["2948-197X"],"issn-type":[{"value":"2948-197X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"15 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.A.S. is a cofounder of Vellum Biosciences and an inventor on intellectual property owned by the University of Pennsylvania related to the PET imaging of genetic therapies. All other authors declare no competing financial or non-financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"59"}}